NCT03885063 is a NA clinical trial of Benjamin Rose Institute Care Consultation (BRI-CC) in Self Neglect, sponsored by The University of Texas Health Science Center, Houston.

Who is sponsoring NCT03885063?

NCT03885063 is sponsored by The University of Texas Health Science Center, Houston.

What drugs are being tested in NCT03885063?

Interventions in NCT03885063: Benjamin Rose Institute Care Consultation (BRI-CC).

What condition does NCT03885063 study?

NCT03885063 studies Self Neglect.

Is NCT03885063 still recruiting?

NCT03885063 is currently terminated. Last updated 1 July 2025.

Last reviewed 2025-07-01 · How we verify

NCT03885063

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Modifying a Telephone Based Care Program to Assess for Self-Neglect

Terminated NA Last updated 1 July 2025

What this trial tests

NA trial testing Benjamin Rose Institute Care Consultation (BRI-CC) in Self Neglect in 22 participants. Terminated before completion.

Timeline

1 April 2019

Primary endpoint
1 July 2020

1 July 2020

Quick facts

Lead sponsor	The University of Texas Health Science Center, Houston
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	22
Start date	1 April 2019
Primary completion	1 July 2020
Estimated completion	1 July 2020
Sites	1 location across United States

Drugs / interventions tested

Benjamin Rose Institute Care Consultation (BRI-CC)

Conditions studied

Self Neglect — all drugs for Self Neglect →

Sponsor

The University of Texas Health Science Center, Houston

Who can join

60 and older, any sex, with Self Neglect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the feasibility of enrollment, attrition, and adherence of Benjamin Rose Institute Care Consultation (BRI-CC) on unmet needs in low-income older adults who screen positive for dementia and their caregiver (CG).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03885063 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
Last refreshed: 1 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03885063.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing